Publicaciones en las que colabora con MANUEL EDUARDO MUÑOZ TORRES (14)

2018

  1. Circulating levels of sclerostin are associated with cardiovascular mortality

    PLoS ONE, Vol. 13, Núm. 6

2011

  1. A nutritional intervention study with hydrolyzed collagen in pre-pubertal Spanish children: Influence on bone modeling biomarkers

    Journal of Pediatric Endocrinology and Metabolism, Vol. 24, Núm. 3-4, pp. 147-153

2010

  1. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor κb in women with postmenopausal osteoporosis

    Menopause, Vol. 17, Núm. 1, pp. 140-144

2008

  1. Effects of raloxifene therapy on circulating osteoprotegerin and RANK ligand levels in post-menopausal osteoporosis

    Journal of Endocrinological Investigation, Vol. 31, Núm. 5, pp. 416-421

2005

  1. The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women

    Osteoporosis International, Vol. 16, Núm. 11, pp. 1368-1374

2003

  1. Performance of quantitative ultrasound in the discrimination of prevalent osteoporotic fractures in a bone metabolic unit

    Bone, Vol. 32, Núm. 5, pp. 571-578

2002

  1. Performance of COLIA1 polymorphism and bone turnover markers to identify postmenopausal women with prevalent vertebral fractures

    Osteoporosis International, Vol. 13, Núm. 6, pp. 506-512

  2. Prevalence of vitamin D deficiency in populations at risk for osteoporosis: Impact on bone integrity

    Medicina Clinica, Vol. 119, Núm. 3, pp. 85-89

2001

  1. Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women

    Journal of Bone and Mineral Research, Vol. 16, Núm. 8, pp. 1408-1415

  2. The contribution of IGF-I to skeletal integrity in postmenopausal women

    Clinical Endocrinology, Vol. 55, Núm. 6, pp. 759-766

1997

  1. Antiresorptive Therapy in Hyperthyroid Patients: Longitudinal Changes in Bone and Mineral Metabolism

    Journal of Clinical Endocrinology and Metabolism, Vol. 82, Núm. 6, pp. 1989-1994

  2. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: Influence of aetiology and menopause

    Clinical Endocrinology, Vol. 47, Núm. 3, pp. 279-285

  3. Identification of metabolic bone disease in patients with endogenous hyperthyroidism: Role of biological markers of bone turnover

    Calcified Tissue International, Vol. 61, Núm. 5, pp. 370-376

1996

  1. Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus

    Calcified Tissue International, Vol. 58, Núm. 5, pp. 316-319